Saving lives, buying time : economics of malaria drugs in an age of resistance / / Committee on the Economics of Antimalarial Drugs, Board on Global Health ; Kenneth J. Arrow, Claire Panosian, and Hellen Gelband, editors

• Pubblicazione: Washington, D.C., : National Academies Press, c2004
• Edizione: 1st ed.
• Descrizione fisica: 1 online resource (384 p.)
• Disciplina: 616.9/362061
• Soggetto topico: Antimalarials - Economic aspects; Pharmaceutical policy; Drug resistance in microorganisms; Malaria - drug therapy; Antimalarials - therapeutic use; Drug Costs; Drug Resistance
• Altri autori: ArrowKenneth Joseph <1921-> PanosianClaire GelbandHellen
• Note generali: Bibliographic Level Mode of Issuance: Monograph
• Nota di bibliografia: Includes bibliographical references and index.
• Nota di contenuto: FrontMatter -- Reviewers -- Preface -- Acknowledgments -- Contents -- Executive Summary -- PART 1 A Response to the Current Crisis -- 1 Malaria Today -- 2 The Cost and Cost-Effectiveness of Antimalarial Drugs -- 3 The Case for a Global Subsidy of Antimalarial Drugs -- 4 An International System for Procuring Antimalarial Drugs -- PART 2 Malaria Basics -- 5 A Brief History of Malaria -- 6 The Parasite, the Mosquito, and the Disease -- 7 The Human and Economic Burden of Malaria -- 8 Malaria Control -- 9 Antimalarial Drugs and Drug Resistance -- PART 3 Advancing Toward Better Malaria Control -- 10 Research and Development for New Antimalarial Drugs -- 11 Maximizing the Effective Use of Antimalarial Drugs -- Acronyms and Abbreviations -- Glossary -- Index.
• Sommario/riassunto: For more than 50 years, low-cost antimalarial drugs silently saved millions of lives and cured billions of debilitating infections. Today, however, these drugs no longer work against the deadliest form of malaria that exists throughout the world. Malaria deaths in sub-Saharan Africa "currently just over one million per year "are rising because of increased resistance to the old, inexpensive drugs. Although effective new drugs called oeartemisinins are available, they are unaffordable for the majority of the affected population, even at a cost of one dollar per course. Saving Lives, Buying Time: Economics of Malaria Drugs in an Age of Resistance examines the history of malaria treatments, provides an overview of the current drug crisis, and offers recommendations on maximizing access to and effectiveness of antimalarial drugs. The book finds that most people in endemic countries will not have access to currently effective combination treatments, which should include an artemisinin, without financing from the global community. Without funding for effective treatment, malaria mortality could double over the next 10 to 20 years and transmission will intensify.
• Titolo autorizzato: Saving lives, buying time
• ISBN: 9786610176120; 9780309165938; 0309165938; 9781280176128; 1280176121; 9780309532334; 0309532337
• Formato: Materiale a stampa
• Livello bibliografico: Monografia
• Lingua di pubblicazione: Inglese
• Record Nr.: 9910959758103321
• Lo trovi qui: Univ. Federico II